132 related articles for article (PubMed ID: 15102682)
1. Human kallikrein gene 11 (KLK11) mRNA overexpression is associated with poor prognosis in patients with epithelial ovarian cancer.
Shigemasa K; Gu L; Tanimoto H; O'Brien TJ; Ohama K
Clin Cancer Res; 2004 Apr; 10(8):2766-70. PubMed ID: 15102682
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of IGF II mRNA-binding protein 1 mRNA is associated with an advanced clinical stage and poor prognosis in patients with ovarian cancer.
Gu L; Shigemasa K; Ohama K
Int J Oncol; 2004 Mar; 24(3):671-8. PubMed ID: 14767552
[TBL] [Abstract][Full Text] [Related]
3. Human kallikrein 8 (hK8/TADG-14) expression is associated with an early clinical stage and favorable prognosis in ovarian cancer.
Shigemasa K; Tian X; Gu L; Tanimoto H; Underwood LJ; O'Brien TJ; Ohama K
Oncol Rep; 2004 Jun; 11(6):1153-9. PubMed ID: 15138549
[TBL] [Abstract][Full Text] [Related]
4. Relative expression levels of Th1 and Th2 cytokine mRNA are independent prognostic factors in patients with ovarian cancer.
Kusuda T; Shigemasa K; Arihiro K; Fujii T; Nagai N; Ohama K
Oncol Rep; 2005 Jun; 13(6):1153-8. PubMed ID: 15870936
[TBL] [Abstract][Full Text] [Related]
5. Skp2 overexpression is a prognostic factor in patients with ovarian adenocarcinoma.
Shigemasa K; Gu L; O'Brien TJ; Ohama K
Clin Cancer Res; 2003 May; 9(5):1756-63. PubMed ID: 12738731
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of testisin, a serine protease expressed by testicular germ cells, in epithelial ovarian tumor cells.
Shigemasa K; Underwood LJ; Beard J; Tanimoto H; Ohama K; Parmley TH; O'Brien TJ
J Soc Gynecol Investig; 2000; 7(6):358-62. PubMed ID: 11111072
[TBL] [Abstract][Full Text] [Related]
7. Increased MCL-1 expression is associated with poor prognosis in ovarian carcinomas.
Shigemasa K; Katoh O; Shiroyama Y; Mihara S; Mukai K; Nagai N; Ohama K
Jpn J Cancer Res; 2002 May; 93(5):542-50. PubMed ID: 12036450
[TBL] [Abstract][Full Text] [Related]
8. The transmembrane protease serine (TMPRSS3/TADG-12) D variant: a potential candidate for diagnosis and therapeutic intervention in ovarian cancer.
Sawasaki T; Shigemasa K; Gu L; Beard JB; O'Brien TJ
Tumour Biol; 2004; 25(3):141-8. PubMed ID: 15361711
[TBL] [Abstract][Full Text] [Related]
9. Stomatin-like protein 2 is overexpressed in epithelial ovarian cancer and predicts poor patient survival.
Sun F; Ding W; He JH; Wang XJ; Ma ZB; Li YF
BMC Cancer; 2015 Oct; 15():746. PubMed ID: 26487491
[TBL] [Abstract][Full Text] [Related]
10. Identification and validation of Kallikrein-ralated peptidase 11 as a novel prognostic marker of gastric cancer based on immunohistochemistry.
Wen YG; Wang Q; Zhou CZ; Yan DW; Qiu GQ; Yang C; Tang HM; Peng ZH
J Surg Oncol; 2011 Oct; 104(5):516-24. PubMed ID: 21618246
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and prognostic significance of human kallikrein 11 (KLK11) mRNA expression levels in patients with laryngeal cancer.
Patsis C; Yiotakis I; Scorilas A
Clin Biochem; 2012 Jun; 45(9):623-30. PubMed ID: 22429520
[TBL] [Abstract][Full Text] [Related]
12. Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas.
Dong Y; Kaushal A; Bui L; Chu S; Fuller PJ; Nicklin J; Samaratunga H; Clements JA
Clin Cancer Res; 2001 Aug; 7(8):2363-71. PubMed ID: 11489814
[TBL] [Abstract][Full Text] [Related]
13. Elevated tumor tissue protein expression levels of kallikrein-related peptidases KLK10 and KLK11 are associated with a better prognosis in advanced high-grade serous ovarian cancer patients.
Geng X; Liu Y; Dreyer T; Bronger H; Drecoll E; Magdolen V; Dorn J
Am J Cancer Res; 2018; 8(9):1856-1864. PubMed ID: 30323977
[TBL] [Abstract][Full Text] [Related]
14. PRSS3 expression is associated with tumor progression and poor prognosis in epithelial ovarian cancer.
Ma R; Ye X; Cheng H; Ma Y; Cui H; Chang X
Gynecol Oncol; 2015 Jun; 137(3):546-52. PubMed ID: 25735255
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of Abelson interactor protein 1 predicts tumor progression and poor outcome in epithelial ovarian cancer.
Zhang J; Tang L; Chen Y; Duan Z; Xiao L; Li W; Liu X; Shen L
Hum Pathol; 2015 Sep; 46(9):1331-40. PubMed ID: 26193797
[TBL] [Abstract][Full Text] [Related]
16. Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis.
Lu KH; Patterson AP; Wang L; Marquez RT; Atkinson EN; Baggerly KA; Ramoth LR; Rosen DG; Liu J; Hellstrom I; Smith D; Hartmann L; Fishman D; Berchuck A; Schmandt R; Whitaker R; Gershenson DM; Mills GB; Bast RC
Clin Cancer Res; 2004 May; 10(10):3291-300. PubMed ID: 15161682
[TBL] [Abstract][Full Text] [Related]
17. KLK11 mRNA expression predicts poor disease-free and overall survival in colorectal adenocarcinoma patients.
Alexopoulou DK; Kontos CK; Christodoulou S; Papadopoulos IN; Scorilas A
Biomark Med; 2014; 8(5):671-85. PubMed ID: 25123036
[TBL] [Abstract][Full Text] [Related]
18. Cyclin E mRNA overexpression in epithelial ovarian cancers: inverse correlation with p53 protein accumulation.
Sawasaki T; Shigemasa K; Shiroyama Y; Kusuda T; Fujii T; Parmley TH; O'Brien TJ; Ohama K
J Soc Gynecol Investig; 2001; 8(3):179-85. PubMed ID: 11390254
[TBL] [Abstract][Full Text] [Related]
19. The Notch pathway in ovarian carcinomas and adenomas.
Hopfer O; Zwahlen D; Fey MF; Aebi S
Br J Cancer; 2005 Sep; 93(6):709-18. PubMed ID: 16136053
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinoma.
Zhang W; Niu C; He W; Hou T; Sun X; Xu L; Zhang Y
Tumour Biol; 2016 May; 37(5):6239-54. PubMed ID: 26615423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
